Purpose: We modified a continuous flow "adult" ventricular assist device (VAD) to support infants and children waiting for heart transplantation, and report our outcomes. Components for VAD set-up (cannulas, grafts, and connectors) are readily available in any cardiac operating room.
Results: From 2010 to 2014 the VAD was placed in 11 consecutive patients. Age ranged from 0.9 to 16 yrs (median = 7 yrs). Body surface area ranged from 0.4 to 2.1 m 2 (median = 0.9 m 2 ). Seven patients were less than 1.0 m 2 . Four patients were on ECMO prior to VAD and 2 had single ventricle/Glenn physiology. Three patients had a recirculation shunt and 3 had use of an oxygenator. Median time on the VAD was 11 days (range 2 to 79 days). In patients with a recirculation shunt, mean patient flow was 1.3 L/min, mean shunt flow was 2.0 L/min. All patients were transplanted, survived, and discharged at a median of 26 days (range, 17-83 days) post-transplantation. There were no infections. There was 1 cerebrovascular accident. Wait list mortality dropped from 10% (5/52) to 3% (2/68) (2007-2010 vs 2011-2014 ) (p = 0.24). VAD mortality dropped from 33% (3/9) to 0% (0/11) (p=0.07).
Conclusions:
The centrifugal VAD successfully supported pediatric patients awaiting heart transplantation. The modified recirculation shunt allows patient flows as low as 700 mL/min. The design facilitates placement of an in-line oxygenator. Compared to traditional pulsatile devices, use of this VAD was associated with a trend toward decreased waitlist and VAD mortality.
